Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma
Nazlı Dizman, Ameish Govindarajan, Zeynep Büşra Zengin, Luís Meza, Nishita Tripathi, Nicolas Sayegh, Daniela V. Castro, Elyse H. Chan, Kyle O. Lee, Sweta R. Prajapati, Matthew I. Feng, Vivian Loo, Makala B. Pace, Shea O'brien, Erin Bailey, Regina Barragán-Carrillo, Alex Chehrazi‐Raffle, Joann Hsu, Xiaochen Li, Neeraj Agarwal, Sumanta K. Pal
Topics & Concepts
MedicineIpilimumabCohortNivolumabRenal cell carcinomaInternal medicineOncologyHazard ratioUnivariate analysisMultivariate analysisCancerImmunotherapyConfidence intervalCircadian rhythm and melatoninCancer Immunotherapy and BiomarkersCancer survivorship and care